Novitium Pharma recalls

Novitium Pharma has 6 recalls on record with the FDA and USDA, the earliest in 2019 and the latest reported on 24 Apr 2024. The most frequent reason is nitrosamine impurity.

Total recalls6since 2019

Last 12 months0reported

Class I00% of total

Ongoing0latest 24 Apr 2024

Recalls per month, last 24 months

click a bar for that month

0Nov '24 0 0 0Feb 0 0 0May 0 0 0Aug 0 0 0Nov 0 0 0Feb 0 0 0May 0 0 0Aug 0 0

Severity split

Class I 0 0%Class II 4 67%Class III 2 33%

Why novitium pharma is recalled

Product types

Stomach & Acid Reflux Medication467%

By year

2024233%
2019467%

All novitium pharma recalls, newest first

6 total

Reported	Class	Recall	Company	Reason	Where
24 Apr 2024Drug	CLASS III	Digoxin Tablets, USP 62.5 mcg (0.0625 mg) recalled by Novitium PharmaDigoxin	Novitium Pharma	Potency & Assay	Nationwide
27 Mar 2024Drug	CLASS III	Digoxin Tablets, USP 125mcg, (0.125 mg) recalled by Novitium PharmaDigoxin	Novitium Pharma	Other	Nationwide
20 Nov 2019Drug	CLASS II	Ranitidine Capsules 300 mg recalled by Novitium Pharma	Novitium Pharma	Nitrosamine Impurity	Nationwide
20 Nov 2019Drug	CLASS II	Ranitidine Capsules 300 mg recalled by Novitium Pharma	Novitium Pharma	Nitrosamine Impurity	Nationwide
20 Nov 2019Drug	CLASS II	Ranitidine Capsules 150 mg recalled by Novitium Pharma	Novitium Pharma	Nitrosamine Impurity	Nationwide
20 Nov 2019Drug	CLASS II	Ranitidine Capsules 150 mg recalled by Novitium Pharma	Novitium Pharma	Nitrosamine Impurity	Nationwide

About this list

Records come from FDA enforcement reports and USDA FSIS notices, grouped by normalised name. A company operating under several names may appear more than once.